Brokerages Set Omada Health, Inc. (NASDAQ:OMDA) Price Target at $22.90

Shares of Omada Health, Inc. (NASDAQ:OMDA) have earned a consensus recommendation of “Moderate Buy” from the eleven research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $22.90.

OMDA has been the subject of several research reports. Wells Fargo & Company started coverage on shares of Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 price objective for the company. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a research note on Thursday, January 22nd. Barclays lowered their price target on shares of Omada Health from $22.00 to $17.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $26.00 price objective on shares of Omada Health in a report on Friday, January 16th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research report on Thursday, January 22nd.

Insider Activity

In other Omada Health news, President Wei-Li Shao sold 5,618 shares of the company’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $16.13, for a total transaction of $90,618.34. Following the transaction, the president directly owned 69,079 shares in the company, valued at approximately $1,114,244.27. This represents a 7.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Sean P. Duffy sold 230,479 shares of the firm’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $15.60, for a total transaction of $3,595,472.40. Following the completion of the transaction, the chief executive officer directly owned 126,644 shares in the company, valued at $1,975,646.40. This trade represents a 64.54% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 276,893 shares of company stock worth $4,336,787.

Hedge Funds Weigh In On Omada Health

Large investors have recently bought and sold shares of the business. Strs Ohio acquired a new stake in Omada Health during the 3rd quarter worth $38,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health in the 2nd quarter valued at $32,000. Bellevue Group AG lifted its stake in shares of Omada Health by 0.7% in the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after purchasing an additional 1,791 shares during the period. Quarry LP bought a new position in shares of Omada Health in the 4th quarter worth $29,000. Finally, Barclays PLC grew its stake in shares of Omada Health by 14.6% during the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock worth $234,000 after purchasing an additional 1,888 shares during the period.

Omada Health Stock Performance

Shares of OMDA stock opened at $14.25 on Friday. The stock’s fifty day moving average is $13.97 and its 200-day moving average is $18.55. The stock has a market capitalization of $825.19 million and a PE ratio of -83.82. Omada Health has a 52 week low of $10.28 and a 52 week high of $28.40.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, March 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.12. The business had revenue of $75.85 million during the quarter.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.